Antipodes Partners LTD Dexcom Inc Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Dexcom Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,617 shares of DXCM stock, worth $93,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,617
Previous 844
91.59%
Holding current value
$93,883
Previous $73,000
47.95%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DXCM
# of Institutions
1,084Shares Held
376MCall Options Held
6.76MPut Options Held
7.24M-
Vanguard Group Inc Valley Forge, PA49.5MShares$2.87 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.9MShares$922 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$637 Million0.05% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...